Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 50/100

ASX ANNOUNCEMENT 07 April 2025 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under s

Key Takeaway: Alterity Therapeutics Limited has issued a notice under section 708A(5)(e) of the Corporations Act 2001. The notice indicates the issuance of 2,470,521,806 fully paid ordinary shares. The announcement was made on April 7, 2025. The company is registered under ACN 080 699 065 and listed on both ASX and NASDAQ.

Market Sentiment Analysis

Full Press Release Details

Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics
Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e) of the
Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
Type: Shares
Class/Description: Fully paid ordinary shares
ASX Code: ATH
Date of Issue: 07 April 2025
Number Issued: 2,470,521,806
The Company gives notice pursuant to section 708A(5)(e)
of the Corporations Act that:
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria

Frequently Asked Questions

Who issued the notice under Section 708A(5)(e)?

The notice was issued by Alterity Therapeutics Limited.

What type of securities are mentioned in the notice?

The notice mentions fully paid ordinary shares.

How many shares were issued by Alterity on 07 April 2025?

2,470,521,806 shares were issued.

What is the ASX code for Alterity Therapeutics?

The ASX code for Alterity Therapeutics is ATH.

Where is Alterity Therapeutics located?

Alterity is located at Level 14, 350 Collins Street, Melbourne, Victoria.

Last updated: Apr 7, 2025